Whether CPEB4 functions as an oncogenic promoter or suppressor in early-stage HCC and whether CPEB4 could be a diagnostic marker and/or therapeutic target in cancers need to be further investigated. This evidence concerns the gene CPEB4 and hepatocellular carcinoma.